Skip to Main Content

Author Details

Glenda Canderan
University of Virginia
2003
20
10
PMIDPaper TitleJournal TitlePublished Year
36865336<i>Schistosoma mansoni</i> infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.medRxiv2023
38077031Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19.Res Sq2023
37745354Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19.bioRxiv2023
37495573In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasms.Blood Cancer J2023
37406029Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.PLoS Negl Trop Dis2023
35386716Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection.Front Immunol2022
34445953Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort.BMC Immunol2021
33621972Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP.Int Arch Allergy Immunol2021
33200147Quantitative measurement of IgG to SARS-CoV-2 proteins using ImmunoCAP.medRxiv2020
30817998Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort.Clin Immunol2019
31323092Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.J Infect Dis2019
27392184Systems biology and the quest for correlates of protection to guide the development of an HIV vaccine.Curr Opin Immunol2016
24911151Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.J Clin Invest2014
24358511A systems framework for vaccine design.Curr Opin Immunol2013
22210916Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.J Immunol2012
20635888T helper 17 T cells do good for cancer immunotherapy.Immunotherapy2010
20711505An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma.PLoS One2010
20978376New approaches to design HIV-1 T-cell vaccines.Curr Opin HIV AIDS2010
16287709Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein.J Exp Med2005
14565664Non-radiolabelled PCR consensus primers and automatic sequencing enable rapid identification of tumor-specific V(H) CDR3 in aggressive B-cell malignancies.Leuk Lymphoma2003
  • 1 - 20 of 20

Recommended Authors

Blake Frey
University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
Alexander F Rosenberg
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 0
Gregory L Szeto
University of Maryland
Career Start Year 2010
Number of shared co-authors 0
Vanessa A York
University of California San Francisco
Career Start Year 2008
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
Michele A Kutzler
Drexel University College of Medicine
Career Start Year 2004
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 0
Paul G Thomas
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 1
Jakob Micha??lsson
Center for Infectious Medicine, Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 0
Alberto Bosque
George Washington University
Career Start Year 2000
Number of shared co-authors 0
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Cristina M Tato
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 0
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 0
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 0
Ligia A Pinto
Frederick National Laboratory for Cancer Research
Career Start Year 1991
Number of shared co-authors 0
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 1
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 0
Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
Career Start Year 1990
Number of shared co-authors 1
Bruce D Walker
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 1
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 0
David B Weiner
Wistar Institute
Career Start Year 1986
Number of shared co-authors 1
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 1
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 1
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 1
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 1

Collaborators

Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers 7
Judith A Woodfolk
University of Virginia School of Medicine
Co-authored papers 6
Lyndsey M Muehling
University of Virginia
Co-authored papers 5
Lisa J Workman
University of Virginia
Co-authored papers 3
Thomas A E Platts-Mills
University of Virginia
Co-authored papers 3
Moses L Joloba
Makerere University.
Co-authored papers 3
Chongzhi Zang
Center for Public Health Genomics, University of Virginia
Co-authored papers 2
Barbara J Mann
University of Virginia
Co-authored papers 1
Michael A Mooney
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 1
Kimberly Gilmour
NIHR Great Ormond Street Hospital BRC
Co-authored papers 1
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Nick P Goplen
Co-authored papers 1
Galit Alter
Co-authored papers 1
Deborah D Murphy
Division of Allergy & Clinical Immunology, University of Virginia
Co-authored papers 1
Neil J Sebire
NIHR Great Ormond Street Biomedical Research Centre
Co-authored papers 1
Katia Basso
Institute for Cancer Genetics, Columbia University
Co-authored papers 1
Release 1.2